Thrombospondin-1: a Proatherosclerotic Protein Augmented by Hyperglycemia
Total Page:16
File Type:pdf, Size:1020Kb
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector From the Eastern Vascular Society Thrombospondin-1: A proatherosclerotic protein augmented by hyperglycemia Kristopher G. Maier, PhD,a,c Xuan Han,a,c Benjamin Sadowitz, MD,a,c Karen L. Gentile, MPS,b Frank A. Middleton, PhD,b and Vivian Gahtan, MD,a,c Syracuse, NY Objective: Diabetes is associated with a more aggressive form of atherosclerosis. Thrombospondin-1 (TSP-1), an extracellular matrix protein, is an acute-phase reactant that induces vascular smooth muscle (VSMC) migration and proliferation in areas of vascular injury and is also up-regulated in VSMCs exposed to hyperglycemia. This study tested the hypothesis that hyperglycemia amplifies the expression of genes induced by TSP-1 in VSMCs. Methods: Human aortic VSMCs were cultured in Dulbecco Modified Eagle’s Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 1% antibiotics. Cells were used between passages three and five. VSMCs were preincubated in DMEM containing 0.2% FBS with 5 mM glucose (normoglycemia), 25 mM glucose (hyperglycemia), 25 mM mannose (osmotic control), TSP-1 (20 g/mL), 25 mM glucose ؉ TSP-1 (20 g/mL), or 25 mM mannose ؉ TSP-1 (20 g/mL). Total RNA was extracted. Microarray analysis was performed and analyzed by analysis of variance. P < .05 was considered significant. Quantitative real-time polymerase chain reaction (rtPCR) was used to confirm selected up-regulated genes. Results: Microarray analysis revealed: (1) hyperglycemia altered 30 genes; (2) TSP-1 altered 212 genes, of which 8 were altered similarly to VSMCs exposed to 25 mM glucose; (3) TSP-1 up-regulated 10 genes associated with atherosclerosis and 4 others with diabetic vascular disease; (4) hyperglycemia combined with TSP-1 altered expression of 2822 genes. The three genes most up-regulated by TSP-1 in a normoglycemic environment were uridine 5=-diphosphoglucose (UDP-glucose) dehydrogenase (UGDH, 127%), transforming growth factor -2 (TGF2, 116%), and hyaluronan synthase 2 (HAS2, 113%). Further, TSP-1 altered the expression of genes in 13 canonical pathways; however, when combined with hyperglycemia, 53 canonical pathways were affected. Conclusion: Quantitative rtPCR confirmed that genes in several of these pathways for TSP-1 and hyperglycemia combined with TSP-1 were up-regulated. These findings suggest that TSP-1 may be germane to the progression of atherosclerosis and may have a large effect with concurrent hyperglycemia. (J Vasc Surg 2010;51:1238-47.) Clinical Relevance: Diabetes is increasing rapidly in the United States. One of the characteristics of this disease is accelerated atherosclerosis. Thrombospondin-1 (TSP-1) has been shown to be involved in atherosclerosis and up-regulated in the tissues of diabetic patients and in animal models of diabetes. Among other actions, TSP-1 has been shown to increase DNA synthesis in vascular smooth muscle cells; however, the specific genes increased have not been completely identified. Further, the influence of hyperglycemia on TSP-1–induced gene expression has not been fully determined. The present study demonstrates that TSP-1 causes the up-regulation of several genes involved in atherosclerosis and diabetes and that hyperglycemia has a substantial effect on this process. Understanding the apparent complex interaction between hyperglycemia and TSP-1 will help identify therapeutic targets and aid in the development of anti-TSP-1 strategies to reduce vascular disease in diabetes. The incidence of type 2 diabetes, a major cause of exceed $200 billion by the year 2020.1 Further, the mor- death, is dramatically increasing in the United States.1 The tality rate ultimately associated with cardiovascular disease cost of diabetes to our health care system is estimated to in type 2 diabetes is approximately 65%.2 The most common cardiovascular complication of dia- From Division of Vascular Surgery and Endovascular Services,a and the b betes is atherosclerosis. Atherosclerosis is a complex process Department of Neuroscience and Physiology, SUNY Upstate Medical involving vascular remodeling in response to vessel injury. University; and the Department of Veterans Affairs VA Healthcare Net- work Upstate New York at Syracuse.c In early atherosclerosis, there are three distinct stages: This study was supported in part by a Bridge Funding grant from SUNY Upstate Medical University, a VA Merit Award, and a Lifeline Student 1. endothelial cell injury and dysfunction trigger medial Research Fellowship from the American Vascular Association. vascular smooth muscle cell (VSMC) proliferation and Competition of interest: none. migration across the internal elastic lamina to form the These data were presented at the Twenty-second meeting of the Eastern neointima; Vascular Society, September 18–20, 2008, Boston, Mass. 2. VSMC proliferation in the neointima3,4; and Correspondence: Vivian Gahtan, MD, SUNY Upstate Medical University College of Medicine, Division of Vascular Surgery and Endovascular 3. VSMCs switch to a synthetic phenotype and produce Services, 750 E Adams St, Syracuse, NY 13210 (e-mail: gahtanv@ extracellular matrix, which further expands the neoin- upstate.edu). tima.3,5,6 The editors and reviewers of this article have no relevant financial relation- ships to disclose per the JVS policy that requires reviewers to decline Mounting evidence indicates that glycoproteins, such review of any manuscript for which they may have a competition of as thrombospondin-1 (TSP-1), have an important role in interest. vascular remodeling by regulating the arterial response to 0741-5214/$36.00 3,5,6 Published by Elsevier Inc. on behalf of the Society for Vascular Surgery. injury. TSP-1 is a matricellular glycoprotein that is not doi:10.1016/j.jvs.2009.11.073 a part of the arterial wall structure.7 TSP-1 is increased 1238 JOURNAL OF VASCULAR SURGERY Volume 51, Number 5 Maier et al 1239 Table I. Sequences of the primers used for quantitative Table II. Genes are listed that were up-regulated by real-time polymerase chain reaction to confirm the thrombospondin-1 in vascular smooth muscle cells as canonical pathways determined by microarraya Gene symbol Sequence (5=-3=) Gene symbol Increase, % Gene description Disease 18 s rRNA UGDH 127.0 UDP-glucose dehydrogenase A Forward GTAACCCGTTGAACCCCATT TGFB2 116.0 Transforming growth factor-2A,D Reverse CCATCCAATCGGTAGTAGCG HAS2 113.0 Hyaluronan synthase 2 A, D TSP-1 SLC2A1 100.0 Solute carrier family 2 A Forward CTGCTCCAATGCCACAGTTC (facilitated glucose Reverse GGAGCCCTCACATCGGTTG transporter), member 1 TGF 2 TIMP3 76.0 Tissue inhibitor of A Forward AGAGTGCCTGAACAACGGATT metalloproteinase 3 Reverse CCATTCGCCTTCTGCTCTT SMAD7 66.0 MAD homolog 7 (Drosophila)A HAS2 THBS1 65.6 Thrombospondin-1 A Forward TCCAAAGAGTGTGGTTCCAA Serpine1 43.9 Serine (or cysteine) peptidase A Reverse GACAGGCTGAGGACGACTTT inhibitor, clade E, member 1 HES1 GART 43.0 Phosphoribosylglycineamide A Forward GGCTGGAGAGGCGGCTAA formyl transferase Reverse GAGAGGTGGGTTGGGGAGTT SRF 42.0 Serum response factor A, D FOS Forward AAAAGGAGAATCCGAAGGGAAA UDP-glucose, uridine 5=-diphosphoglucose. a Reverse GTCTGTCTCCGCTTGGAGTGTAT A standard cutoff of up-regulation by Ն30% was used. Genes are also UGDH identified by their association with atherosclerosis (A) or diabetes (D). Forward GCCAGGACTAAAAGAAGTGGTAG Reverse TGCACAATGCGTCTAGCACAA NFAT5 Previous studies have shown that hyperglycemia in- Forward CACCGCTTGTCTGACTCATT 16 Reverse GCCCAAGTCCCTCTACTCG creases the expression of TSP-1 in VSMCs. Further, PIK3CA TSP-1 is expressed in the arterial wall of animal models of Forward CCTGATCTTCCTCGTGCTGCTC type 2 diabetes and in tissues from patients with diabe- Reverse ATGCCAATGGACAGTGTTCCTCTT tes.17,18 Given that TSP-1 contributes to the development ROCK2 Forward TTGTTTTTCCTCAAAGCAGGA of atherosclerosis, TSP-1 may be important in this compli- Reverse CGCTGATCCGAGACCCT cation of diabetes. The role TSP-1 has in this complication SOS1 of diabetes warrants further study. Forward CGAGCCCTTTTCACTCAAGCAA The mechanisms of TSP-1–induced VSMC prolifera- Reverse CAGGAGGAGGGACAGGCACTTC tion, VSMC migration, and atherosclerosis in type 2 diabe- tes have not been well characterized. The goal of this project was to examine the early molecular changes in acutely in areas of arterial injury and is expressed in athero- VSMCs associated with hyperglycemia and TSP-1. In the sclerotic plaque.8-12 The term “matricellular” refers to present study, we hypothesized that hyperglycemia ampli- matrix proteins with a modular structure that do not play a fies the expression of genes induced by TSP-1 in VSMCs. part in vascular wall structural integrity. Rather, these pro- teins influence vascular physiology by binding other MATERIALS AND METHODS proteins of the extracellular matrix, cell-surface receptors, Materials. Purified TSP-1 (derived from human plate- proteases, and cytokines, thus allowing these proteins to lets) was obtained from Calbiochem (Gibbstown, NJ). exert multiple effects on cells.8,13 This type of complex Glucose and mannose were obtained from Sigma (St. interaction clarifies the mechanisms by which TSP-1 exerts Louis, Mo). different effects on cells such as having both antiadhesive Cell culture. Human VSMCs and human growth me- and proadhesive properties.8 dia were purchased from Cell Applications (San Diego, Findings that implicate the role of TSP-1 in the devel- Calif). Growth media was supplemented with 1% vol/vol opment of vascular remodeling are that TSP-1 causes